ARTICLE | Company News
Melanoma Diagnostics Inc., Myriad Genetics deal
December 13, 2010 8:00 AM UTC
Myriad Genetics received exclusive, worldwide rights to Melanoma Diagnostics' technology to develop and commercialize tests to detect malignant melanoma. Myriad expects to launch a melanoma diagnostic...